Many environmental chemicals and pesticides have been found to be estrogenic and have been shown to stimulate the growth of esrogen receptor-positive (ER-positive) human breast cancer cells. Since it is difficult to avoid human exposure to environmental etrogens, a potentially important area of research is the development of dietary mategies to prvent the stmulated growth of breast tumors by environmental estogens. In this context, the inhbitory action ofc min and a combination ofcurcumin and isoflavonoids were studied in ER-positive human breast cancer cells (MCF-7 and T47D) and ER-negative MDA-MB-231 cells induced by the pesticide o,p'-DDT and the environmental pollutants 4-nonylphenol and 4-octylphenol. The median inhibitory concentration (IC5,) for curcumin in T47D cells was 10 pM when measured at either a 48-hr or a 6-day incubation time. The IC50 value for curcumin was within the 8-10 pM range for inhibiting the growth of T47D cells induced by a 10-pM concentration each of 4-nonylphenol, 4-octylphenol, and o,p'-DDT. The IC5, for curcumin in MCF-7 cells induced by 10 pM of either oq/-DDT, 4-octylphenol, or 4-nonylphenol were 9, 39, and >50 pM, respectively. A mination of curcun and isoflavonoids was able to inhibit the induced growth of ER-positive cells up to 95%. For MDA-MB-231 cells, the IC50 for rcmn was 17 pM, which was reduced to 11 pM in the presence of 25 pM genistein. Curcumin and genisein induce drastic changes in the morphological shape of both ER-positive and ER-negative cdls. Data preted here indicate that a mixtue of curcumin and isoflavonoids is the most potent inhibitor against the growth ofhuman breast tumor cells. These data suggest that combinations of natural plant compounds may have preventive and therapeutic applications against the growth ofbreast tumors induced by environmentl estogens.
Environmental chemicals may be involved in the etiology of a variety of human cancers. The cause for the majority of human tumors has been attributed to exposure to environmental carcinogens, pollutants, pesticides, drugs, UV-radiation, and tobacco products (1). A nutritional deficit or surplus or the absence of preventive micronutrients in the diet can further increase the susceptibility for developing cancers. In addition, tumors induced by environmental pollutants may be prevented by dietary strategies. It is therefore plausible that an imbalance between the exposure to cancer-causing environmental factors and the dietary intake of preventive nutrients facilitates the initiation and growth of tumors. The incidence of breast tumors in women is increasing, and environmental chemicals have been implicated in part for this increase (2) . In vitro and in vivo data have shown that endogenous estrogens, such as estradiol, or environmental estrogens [e.g., DDT, polychlorinated biphenyls, 4- nonylphenol (4-NP), 4-octylphenol (4-OP), and many others] promote mammary carcinogenesis (3) (4) (5) . A majority of the human breast tumor cells express estrogen receptors, and the growth of such tumors is generally estrogen dependent. The growth of estrogen receptor (ER)-positive tumors can be inhibited by antiestrogens blocking the estrogen receptor (6, 7) or by inhibiting estrogen production (8) .
Since it may not be possible to avoid human exposure to environmental chemicals, developing nutritional strategies for prevention and control of breast tumors induced by environmental estrogens is a highly relevant concept. In this context, natural plant-derived foods that modulate tumor growth also could form a framework for developing safe chemopreventive drugs. Two such dietary natural plantderived products of interest are curcumin and isoflavonoids. Curcumin (diferuloylmethane)-the major constituent of turmeric (a spice used in Indian dishes), which is isolated from the rhizomes of the Curcuma longa Linn plant-has shown anticarcinogenic properties in animal and cell models. It inhibits skin, forestomach, stomach, and colon tumors in animals (9) (10) (11) (12) (13) (14) and mammary tumorigenesis in rats (15 (29) . The effect of low or high levels of isoflavonoids would yield undesirable results. Considering these limitations, studies of the effect of the combination of curcumin and isoflavonoids were initiated in our laboratory, where concentrations of individual compounds could be controlled to achieve the maximum beneficial effects against the growth ofbreast cells (31) .
We previously reported that the combination of curcumin and genistein is the most sensitive inhibitor against estrogenic pesticide-induced growth of ER-positive MCF-7 human breast cancer cells (31) . Since Growth of cells in control medium without curcumin was normalized to 100%. Cell culture and growth procedure. Estrogen receptor-positive MCF-7 and T47D and ER-negative MDA-MB-231 human breast cancer cells were grown in phenol red RPMI 1640 media (Gibco BRL, Grand Island, NY) supplemented with 5% fetal calf serum (FCS) and 5 ml 10,000 U/ml of penicillin/streptomycin in an incubator maintained at 5% CO2 95% air and 100% humidity at 37°C.
Prior to each experiment with MCF-7 and T47D cells, we replaced phenol red maintenance media with phenol red-free media for 24 hr. The phenol red-free media was then replaced with phenol red-free RPMI 1640 media supplemented with 5% DCC-stripped bovine serum for 48 hr. Cells were detached by adding 2-3 ml 2.5% trypsin solution. After 15 min, cells were harvested and washed with Ca-Mg free phosphate buffered saline (PBS). Washed cells were suspended in phenol red-free RPMI 1640 media supplemented with 5% DCC and antibiotics and were gently agitated by passing up and down in a pipet to get a single cell suspension. Cells were counted by a Coulter Counter. Cells (2-3 x 105/ml) were plated in a 12-well culture plate (2 ml/well) and were allowed to attach for 48 hr.
After 48 hr, media was removed and replaced by test media (prepared as above) containing the appropriate concentrations 
Results

Effect of Curcumin on the Growth of T47D Cells
The T47D cells used in these studies respond to 17p-estradiol (i.e., ER-positive).
The effect of curcumin on the growth of these cells as a function of the concentration and time of incubation is shown in Figure 1 . The cell growth in 2% FCS has been normalized to 100% for data shown in Figure 1 . The cell growth is inhibited as a function of curcumin concentration when measured on day 6 while the inhibition levels off at approximately 40% when measured after 48 hr (Fig. 1) . However, the concentration of curcumin required to inhibit the growth of T47D cells by 50% (IC50) is approximately the same (10 ,uM) when measured after 48 hr or on day 6. Effect of Curcumin on Induced Proliferation of ER-positive Cells MCF-7 cells. It Table 2 show a synergistic inhibitory effect in the presence of the combination of curcumin and isoflavonoids. As shown in Table 2 , the 4-NP-induced cell growth is reduced to 48% (52% inhibition) in the presence of a mixture of curcumin (10 pM) and genistein (25 FM (Fig. 3) , while a mixture of curcumin (15 pM) and genistein (10 and 25 pM) is able to reduce the induced growth to about 15% (Table 1) Figure 4 . Curcumin was found to be cytotoxic for these cells. The IC50 of curcumin is 17 pM (Fig. 4) . In the presence of 25 pM genistein, the IC50 of curcumin is reduced to 11 pM (Fig. 4) . The IC50 value for genistein in the presence of 10 pM of curcumin is about 70 pM.
Cell Morphology Figure 5A and Figure 6A show the normal shape of MDA-MB-231 and MCF-7 cells, respectively, growing in culture at 37°C. When these cells were treated with curcumin (20 IM) for 48 hr, we observed a profound change in the shape of MDA-MB-231 ( Fig.   SB ) and MCF-7 cells (Fig. 6B) . in phenol red-free media and 5% DCC serum responded to curcumin plus genistein in a similar manner as MDA-MB-231 cells in standard medium treated with curcumin (data not shown).
The TUNEL labeling for apoptosis demonstrated that curcumin treatment increased apoptosis, but the absolute number was small. Apoptosis data showed a 10% increase in the apoptotic death of cells when measured after 48 hr of treatment with 10 pM of curcumin.
Discussion
The data presented in this paper demonstrate several major points: 1) curcumin can inhibit the growth of human breast cancer cells independent of the expression of estrogen receptors; 2) curcumin more effectively inhibits the growth of ER-nega- (36) . PLCgl may produce diacyl glycerol and inositol 1,4,5-triphosphate; these signaling compounds can stimulate protein kinase C, which has been implicated in modulating cell growth. Curcumin may be inhibiting the growth of both ERpositive and ER-negative cells by directly modulating the activities of COX, LOX, PLA2, and PLCgl enzymes, including the activity of protein kinase C, as has been reported in colon tumors (12, 13) .
Other feasible mechanisms of action of curcumin could involve suppression of the activities of protein kinases, (e.g., kinase C and tyrosine kinase) (18, 20) , many types of transcription factors (such as hydrogen peroxide, tumor necrosis factor, NF-KB) (21), and proto-oncogenes (22, 23) .
The cell morphology data presented in this paper show that cells become round after 48 hr of treatment with curcumin or curcumin plus genistein. These data suggest the possibility of a disruption in cell matrix and a reduction in cytoplasmic contents of curcumin and curcumin plus genistein-treated cells. These initial structural disruptions could direct cells to initiate the apoptotic or programmed cell death process. There is some indication by TUNEL data (10% increase in apoptosis) that this process may actually be triggered. However, more data are needed for determining the exact mechanism by which curcumin inhibits the induced growth ofbreast tumor cells.
Genistein is well recognized for its inhibition of various kinds of protein kinases. There is a possibility that genistein inhibits cell growth by its direct action on protein kinases (e.g., protein kinase C, tyrosine kinase, MAP-kinase). Protein kinases are involved in the phosphorylation of estrogen and progesterone receptors. Phosphorylated receptors are involved in activating transcription factors. Since curcumin and genistein have been shown to have a synergistic effect against the growth of both ER-positive and ER-negative cells, the action of these compounds may be through separate pathways. The concentration and time-dependent growth inhibition data suggest that curcumin and isoflavonoids may not be competing for the same target in order to block the growth. The exact mechanism of action of these compounds remains to be elucidated.
These results support the concept that a combination of natural chemopreventive nutrients is more potent than individual compounds against suppressing the growth of breast tumors induced either by environmental chemicals or other carcinogens (31) . Also, the in vitro data presented in this paper constitute the framework for further studies in animal models and clinical trials. Data on natural plant compounds may further be helpful in developing new therapeutic agents.
